The Anti-aging Therapeutics Market Size is valued at 692.66 Million in 2023 and is predicted to reach 2,527.33 Million by the year 2031 at a 17.62% CAGR during the forecast period for 2024-2031.
Anti-aging treatment combines cutting-edge research and medical technology to identify, prevent, cure, and reverse age-related dysfunctions, illnesses, and diseases as early as possible. As a result, anti-aging preventive medicine and healthcare are critical components in assisting senior people in living healthy and active lives. The progress of technology offers the detection, prevention, and treatment of age-related diseases and the promotion of research into strategies to slow and optimize the human ageing process. Researchers have made considerable progress in understanding stem cell ageing and the molecular processes behind this process during the last decade. Few studies have also validated the extrinsic factors, while transplantation experiments have found the intrinsic components that induce an age-dependent reduction in stem cell quantity and function.
The rise in consumer demand for anti-aging therapeutics, combined with an increase in lifestyle standards and income among the world's population, is the primary factor driving the growth of the anti-aging therapeutics market over the forecast period. Furthermore, technological advancements and increased investment in research and development activities by major players for the development of highly safe and efficient treatment solutions are expected to propel the anti-aging therapeutics market globally.
Market Segmentation:
The Anti-aging Therapeutics market is segmented on the basis of type of molecule, type of aging and mechanism of action. Based on type of molecule, the market is segmented as Biologics and Small Molecules. The type of aging segment includes Cellular Aging, Immune Aging, Metabolic Aging and Others. By mechanism of action, the market is segmented into Senolytic, Cell Regeneration, mTOR inhibitor/Modulator, AMP-kinase/AMP Activator, Mitochondria Inhibitor/Modulator and Others.
Based on type of molecule, the small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market
The small molecule segment is accounted as a major contributor in the Anti-aging Therapeutics market. Small molecules can delay multiple aging diseases and increase lifespan. In theory, such molecules could simultaneously prevent dozens of diseases, potentially extending healthy years of life.
Cellular aging segment witnessed growth at a rapid rate
Cellular aging is generally defined as a progressive decrease in resistance to stress and other cellular damages, resulting in a gradual loss of cellular functions and, eventually, cell demise. Cells age as they divide, multiply, and perform their assigned functions. And as they age, the body has remarkable mechanisms in place to care for aging cells and replenish them with new ones.
In the region, the North America Anti-aging Therapeutics market holds a significant revenue share.
The anti-aging therapeutics market in North America is expected to grow significantly due to the availability of well-established infrastructure, key market players, and the region's increasing average life expectancy and median age. However, the rising popularity of anti-aging therapeutics and favorable reimbursement policies are expected to boost regional growth during the forecast period. Furthermore, companies in the region are working hard to improve their market position through R&D and new product launches. Moreover, Asia Pacific is the most populous region on the planet, with a sizable market for anti-aging therapeutics. The development of infrastructure and facilities to advance stem cell research in both developed and emerging nations is driving market expansion in this region.
Competitive Landscape:
Some major key players in the Anti-aging Therapeutics Market:
- AgelessRx,
- ANOVA Institute for Regenerative Medicine,
- Betterhumans,
- BioAge Labs,
- BIOPHYTIS BSA,
- bioXcellerator,
- Cambrian Biopharma,
- CytoMed Therapeutics,
- ai,
- Rejuvenate Bio,
- Rejenevie Therapeutics,
- MyMD Pharmaceuticals,
- Intervene Immune, Inc.,
- CohBar, Inc.,
- Alkahest,
- Athersys Inc,
- BHB Therapeutics,
- Biosplice,
- Cyclo Therapeutics,
- Denali Therapeutics,
- Elysium Health,
- Genome Protection,
- GenSight Biologics,
- Intervene Immune,
- Khondrian,
- Longeveron,
- LyGenesis,
- Mesoblast,
- Minovia Therapeutics,
- Mitobridge,
- Navitor Pharmaceuticals,
- NeuroTrack,
- Nuchido,
- NuSirt,
- OneSkin Technologies,
- PharmatrophiX,
- Proteostasis Therapeutics,
- Retrotope,
- Stealth Biotherapeutics,
- TA Sciences,
- Unity Biotechnology
- Younger Phenotype,
- Other Prominent Players.
Anti-aging Therapeutics Market Report Scope:
|
Report Attribute |
Specifications |
|
Market size value in 2022 |
USD 692.66 Million |
|
Revenue forecast in 2031 |
USD 2,527.33 Million |
|
Growth rate CAGR |
CAGR of 17.62% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments covered |
Type of Molecule, Type of Aging, Mechanism of Action |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
AgelessRx, ANOVA Institute for Regenerative Medicine, Betterhumans, BioAge Labs, BIOPHYTIS BSA, bioXcellerator, Cambrian Biopharma, CytoMed Therapeutics, Gero.ai, Rejuvenate Bio, Rejenevie Therapeutics, MyMD Pharmaceuticals, Intervene Immune, Inc., CohBar, Inc., Alkahest, Athersys Inc, BHB Therapeutics, Biosplice, Cyclo Therapeutics, Denali Therapeutics, Elysium Health, Genome Protection, GenSight Biologics, Intervene Immune, Khondrian, Longeveron, LyGenesis, Mesoblast, Minovia Therapeutics, Mitobridge, Navitor Pharmaceuticals, NeuroTrack, Nuchido, NuSirt, OneSkin Technologies, PharmatrophiX, Proteostasis Therapeutics, Retrotope, Stealth Biotherapeutics, TA Sciences, Unity BiotechnologyYounger Phenotype, and Other Prominent Players. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
